EMAMI LTD.-$ - 531162 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2022 for Suraj Finvest Pvt Ltd Q2FY23 Quarterly Result Announced for Emami Ltd.
FMCG Emami announced Q2FY23 results: Q2FY23: Consolidated net sales at Rs 807 crore grew by 4%; 3-year CAGR of 8% Growth of 8% excluding Pain Management, Healthcare range and Helios Lifestyle Correction in Pain Management and Healthcare range due to exceptionally high base in previous year PBT at Rs 186 crore declined by 18%, however, it grew by 17% on a 3-year CAGR basis. PAT at Rs 180 crore declined by 3%; however, it grew by 23% on a 3-year CAGR basis Board of Directors declared an interim dividend at 400% i.e. Rs 4/- per equity share Helios Lifestyle Pvt. Ltd (The Man Company) became a subsidiary of Emami Ltd after an increase of stake from 49.53% to 50.40% Mr Harsha V Agarwal, Vice Chairman and Managing Director, Emami Limited said: “We are happy that despite challenging business & industry environment, the first half delivered net sales growth of 10%. With our strong focus on cost control, distribution expansion, aggressive marketing campaigns and driving penetration, we expect to deliver double-digit growth with healthy margins in the second half. Thus, on a full-year basis, we aspire to deliver double-digit growth with higher EBIDTA than the previous year for our core business.” Mr Mohan Goenka, Vice Chairman and Whole-Time Director, Emami Limited said: “Consumer demand remained muted across markets with high inflation affecting consumption, especially in the rural markets. As anticipated, we witnessed a correction in the COVID contextual portfolio of pain management and healthcare products which grew significantly during the last two years. In the given context, the quarter delivered a low single-digit growth on a year-on-year basis, however, the 3-year CAGR has been impressive with a high single-digit growth of 8% if compared to pre-pandemic levels. Our international business also maintained its strong run, delivering a double-digit growth of 17%, notwithstanding various global and geo-political uncertainties.” Result PDF EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release in relation to the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended 30th September, 2022 EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on Company's Performance update for the quarter ended 30th September, 2022. EMAMI LTD.-$ - 531162 - Board Meeting Outcome for Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September, 2022 And Declaration Of Interim Dividend FY 2022-23
Pursuant to Regulation 30 & 33 (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith Unaudited Financial results of the Company along with Limited Review Reports for the Second Quarter and Half Year ended 30th September, 2022 which have been duly approved by the Board of Directors of the company in its meeting held today i.e. 11th November, 2022. Further pursuant to Regulation 30 & 43 (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the company in its meeting held today has declared payment of Interim Dividend of Rs. 4 /- per equity share of Re. 1/- each fully paid-up i.e. 400% on the equity shares of the company for the Financial Year 2022-23. EMAMI LTD.-$ - 531162 - Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2022 And Declaration Of Interim Dividend FY 2022-23
Pursuant to Regulation 30 & 33 (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith Unaudited Financial results of the Company along with Limited Review Reports for the Second Quarter and Half Year ended 30th September, 2022 which have been duly approved by the Board of Directors of the company in its meeting held today i.e. 11th November, 2022. The full format of the Standalone and Consolidated Financial Results for the Second Quarter and Half Year ended 30th September, 2022
Debabrata Mukherjee joins Emami Agrotech as CMO and strategy officer
Mukherjee comes with over 28 years of experience in general management, marketing and sales operation, business strategy and innovation. As the CMO at the UB Group, he was responsible for managing a diverse set of local and global brands like Kingfisher, Ultra, Heineken and Amstel. EMAMI LTD.-$ - 531162 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor's Conference call has been organized on Friday, 11th November, 2022 at 4:00 pm IST , to discuss the Company's business strategy and outlook post the declaration of its Q2FY23 results. EMAMI LTD.-$ - 531162 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 08, 2022 for Sneha Enclave Pvt Ltd